Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Investments available for sale:
Fixed maturities, at fair value (amortized cost $160,895,869 and $159,912,511)	$ 160,960,784	$ 178,555,225
Equity securities, at fair value (cost $0 and $35,712,633)	0	58,848,491	[1]
Equity securities, at fair value (cost $34,885,107 and $0)	67,664,482	0
Equity securities, at cost	12,118,617	0
Mortgage loans on real estate at amortized cost	9,069,111	17,314,477
Investment real estate, net	52,518,577	50,504,550
Notes receivable	23,717,312	19,004,016
Policy loans	9,204,222	9,559,142
Total investments	335,253,105	333,785,901
Cash and cash equivalents	20,150,162	25,434,199
Accrued investment income	2,119,882	2,990,721
Reinsurance receivables:
Future policy benefits	26,117,936	26,488,346
Policy claims and other benefits	4,053,882	3,882,047
Cost of insurance acquired	5,622,227	6,428,292
Property and equipment, net of accumulated depreciation	688,567	1,118,826
Income taxes receivable	279,333	549,851
Other assets	1,263,242	5,766,901
Total assets	395,548,336	406,445,084
Policy liabilities and accruals:
Future policy benefits	253,852,368	259,469,205
Policy claims and benefits payable	4,267,481	3,777,175
Other policyholder funds	372,072	408,790
Dividend and endowment accumulations	14,608,838	14,601,645
Deferred income taxes	9,113,480	10,996,404
Other liabilities	6,257,387	6,760,347
Total liabilities	288,471,626	296,013,566
Shareholders' equity:
Common stock - no par value, stated value $.001 per share. Authorized 7,000,000 shares - 3,295,270 and 3,333,337 shares outstanding	3,296	3,333
Additional paid-in capital	36,567,865	37,536,164
Retained earnings	69,708,901	39,040,456
Accumulated other comprehensive income	62,495	32,952,338
Total UTG shareholders' equity	106,342,557	109,532,291
Noncontrolling interests	734,153	899,227
Total shareholders' equity	107,076,710	110,431,518
Total liabilities and shareholders' equity	$ 395,548,336	$ 406,445,084

[1] Effective January 1, 2018, the Company adopted ASU 2016-01 and equity securities are no longer classified as available-for-sale. Prior periods have not been restated to conform to the current presentation. See Note 1 to the Consolidated Financial Statements for additional information.